Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Isaac García-Yébenes"'
Autor:
Nuria DeGregorio-Rocasolano, Octavi Martí-Sistac, Jovita Ponce, María Castelló-Ruiz, Mònica Millán, Verónica Guirao, Isaac García-Yébenes, Juan B. Salom, Pedro Ramos-Cabrer, Enrique Alborch, Ignacio Lizasoain, José Castillo, Antoni Dávalos, Teresa Gasull
Publikováno v:
Redox Biology, Vol 15, Iss C, Pp 143-158 (2018)
Despite transferrin being the main circulating carrier of iron in body fluids, and iron overload conditions being known to worsen stroke outcome through reactive oxygen species (ROS)-induced damage, the contribution of blood transferrin saturation (T
Externí odkaz:
https://doaj.org/article/facd8b78a4874d8e865b236e82696fcb
Autor:
Violeta Durán-Laforet, David Fernández-López, Alicia García-Culebras, Juan González-Hijón, Ana Moraga, Sara Palma-Tortosa, Isaac García-Yébenes, Adrián Vega-Pérez, Ignacio Lizasoain, María Ángeles Moro
Publikováno v:
Frontiers in Neuroscience, Vol 13 (2019)
Tissue perfusion is a necessary condition for vessel survival that can be compromised under ischemic conditions. Following stroke, delayed effects of early brain reperfusion on the vascular substrate necessary for remodeling, perfusion and maintenanc
Externí odkaz:
https://doaj.org/article/d39a55d1ec644ffabb8a6e593be135b8
Autor:
Carme Gubern-Mérida, Elisabet Kádár, Mar Castellanos, María A. Moro, Ignacio Lizasoain, Juan M. Sanchez, Irene Puig-Parnau, Joaquín Serena, Isaac García-Yébenes, Gemma Huguet, Pau Comajoan
Thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for acute ischemic stroke. However, its administration is still limited due to the associated increased risk of hemorrhagic transformat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437231409bb24f18f1aca74ce81eef77
https://doi.org/10.21203/rs.3.rs-551455/v1
https://doi.org/10.21203/rs.3.rs-551455/v1
Autor:
Jesús M. Pradillo, Raquel Ferreras-Martín, Isaac García-Yébenes, Ana Moraga, Olivia Hurtado, María A. Moro, Alicia García-Culebras, Ignacio Lizasoain, Sara Palma-Tortosa
Publikováno v:
Brain, Behavior, and Immunity. 80:573-582
Ischemic stroke is one of the leading causes of death and disability with an urgent need for innovative therapies, especially targeting the chronic phase. New evidence has emerged showing that Toll-Like Receptor 4 (TLR4), a key mediator of brain dama
Autor:
Juan González-Hijón, Alicia García-Culebras, David Fernández-López, Violeta Durán-Laforet, Adrián Vega-Pérez, María A. Moro, Ana Moraga, Sara Palma-Tortosa, Isaac García-Yébenes, Ignacio Lizasoain
Publikováno v:
Frontiers in Neuroscience, Vol 13 (2019)
Frontiers in Neuroscience
Frontiers in Neuroscience
Tissue perfusion is a necessary condition for vessel survival that can be compromised under ischemic conditions. Following stroke, delayed effects of early brain reperfusion on the vascular substrate necessary for remodelling, perfusion and maintenan
Autor:
Jean-Jacques Parienti, Stephen Meairs, Mohamad El Amki, Maxime Gauberti, Marc Fatar, Isabelle Margaill, Benoit Haelewyn, Richard Macrez, Josune Orbe, Denis Vivien, Alan R. Young, Saema Ansar, Marina Rubio, Emmanuel Touzé, Samaneh Maysami, Nancy J. Rothwell, Ignacio Lizasoain, Stuart M. Allan, Christian Waeber, T.-H. Cho, Eng H. Lo, Francesco Campos, Anne Durand, José A. Páramo, Isaac García-Yébenes, Norbert Nighoghossian, Saskia Grudzenski, Cyrille Orset
Publikováno v:
University of Manchester-PURE
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Background and Purpose— The debate over the fact that experimental drugs proposed for the treatment of stroke fail in the translation to the clinical situation has attracted considerable attention in the literature. In this context, we present a re
Autor:
Juan B. Salom, Enrique Alborch, Teresa Gasull, Isaac García-Yébenes, Pedro Ramos-Cabrer, Ignacio Lizasoain, María Castelló-Ruiz, Jovita Ponce, Verónica Guirao, Mónica Millán, José Castillo, Antoni Dávalos, Octavi Martí-Sistac, Nuria DeGregorio-Rocasolano
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Redox Biology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Redox Biology, Vol 15, Iss C, Pp 143-158 (2018)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Universitat Autònoma de Barcelona
Redox Biology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Redox Biology, Vol 15, Iss C, Pp 143-158 (2018)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Despite transferrin being the main circulating carrier of iron in body fluids, and iron overload conditions being known to worsen stroke outcome through reactive oxygen species (ROS)-induced damage, the contribution of blood transferrin saturation (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::810b789a7d186b24d714a1ffbfc93687
https://ddd.uab.cat/record/190741
https://ddd.uab.cat/record/190741
Autor:
Carlos Avendaño, David Fernández-López, María A. Moro, Mar Castellanos, Carolina Peña-Martínez, Isaac García-Yébenes, Teresa Gasull, Jaime Díaz-Guzmán, Ignacio Lizasoain, Pilar Negredo, Antoni Dávalos, Alicia García-Culebras
Publikováno v:
Stroke
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background and Purpose— Recanalization with tPA (tissue-type plasminogen activator) is the only pharmacological therapy available for patients with ischemic stroke. However, the percentage of patients who may receive this therapy is limited by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7868ed0195a8ca8b93cbf3bd847da5d6
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5495
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5495
Autor:
Juan de la Parra, Jaime Díaz-Guzmán, Ignacio Lizasoain, Sara Palma-Tortosa, Jesús M. Pradillo, Ana Moraga, Isaac García-Yébenes, María A. Moro, María Isabel Cuartero, Ana L. Barrios-Muñoz, Alicia García-Culebras, Violeta Durán-Laforet
Publikováno v:
Stroke. 48(6)
Background and Purpose— Hemorrhagic transformation is the main complication of revascularization therapies after stroke. Toll-like receptor 4 (TLR4) is implicated in cerebral damage and inflammation in stroke. This study was designed to determine t
Autor:
Ignacio Lizasoain, María A. Moro, Jesús M. Pradillo, David Fernández-López, Isaac García-Yébenes, José Martínez-Orgado
Publikováno v:
Stroke. 41:2956-2964
Background and Purpose— The endocannabinoid system has been involved in the modulation of neural stem cells proliferation, survival and differentiation as well as in the generation of new oligodendrocyte progenitors in the postnatal brain. The pres